# A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

> **NCT02249104** · PHASE4 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 28 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Adapalene/benzoyl peroxide gel, 0.1%/2.5%
- **OTHER:** Cetaphil Acne Regimen

## Key facts

- **NCT ID:** NCT02249104
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02249104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02249104, "A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02249104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*